Cite
Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL): predictive role of minimal residual disease monitoring on relapse
MLA
Miglino, Maurizio, et al. Allogeneic Bone Marrow Transplantation (BMT) for Adults with Acute Lymphoblastic Leukemia (ALL): Predictive Role of Minimal Residual Disease Monitoring on Relapse. Jan. 2002. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3710..9ccd1bf11f8dc0abfcac7f3e7736dcc1&authtype=sso&custid=ns315887.
APA
Miglino, M., Berisso, G., Grasso, R., Canepa, L., Verdiani, S., Clavio, M., Pierri, I., Pietrasanta, D., Gatto, S., Varaldo, R., Ballerini, F., Verdiani, S., Casarino, L., Destefano, F., Sessarego, M., Dominietto, A., Raiola, A., Bregante, S., Di Grazia, C., … Bacigalupo, A. (2002). Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL): predictive role of minimal residual disease monitoring on relapse.
Chicago
Miglino, Maurizio, G Berisso, R Grasso, L Canepa, Simonetta Verdiani, M Clavio, Ivana Pierri, et al. 2002. “Allogeneic Bone Marrow Transplantation (BMT) for Adults with Acute Lymphoblastic Leukemia (ALL): Predictive Role of Minimal Residual Disease Monitoring on Relapse,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3710..9ccd1bf11f8dc0abfcac7f3e7736dcc1&authtype=sso&custid=ns315887.